ImmunoMet Therapeutics

ImmunoMet Therapeutics

ImmunoMet’s R&D program is focused on utilizing cellular metabolism to develop novel cancer and immuno-oncology therapies:

  • Cancer metabolism designed to disrupt a tumor’s energy source using OXPHOS inhibitors to treat drug resistant and relapse cancers
  • Immuno-oncology targeting immune suppressor cells to enhance the response of current immunnotherapy
Area of focus: 
Oncology
Commencement date: 
02/01/2016

Share